Organon & Co OGN:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:15 PM EDT
21.00quote price arrow up+0.06 (+0.29%)
Volume
33,356
Close
20.94quote price arrow up+0.52 (+2.55%)
Volume
1,895,817
52 week range
10.84 - 24.08
Loading...
  • Open20.57
  • Day High21.08
  • Day Low20.47
  • Prev Close20.42
  • 52 Week High24.08
  • 52 Week High Date08/08/23
  • 52 Week Low10.84
  • 52 Week Low Date12/06/23

Key Stats

  • Market Cap5.385B
  • Shares Out257.17M
  • 10 Day Average Volume2.58M
  • Dividend1.12
  • Dividend Yield5.35%
  • Beta0.77
  • YTD % Change45.21

KEY STATS

  • Open20.57
  • Day High21.08
  • Day Low20.47
  • Prev Close20.42
  • 52 Week High24.08
  • 52 Week High Date08/08/23
  • 52 Week Low10.84
  • 52 Week Low Date12/06/23
  • Market Cap5.385B
  • Shares Out257.17M
  • 10 Day Average Volume2.58M
  • Dividend1.12
  • Dividend Yield5.35%
  • Beta0.77
  • YTD % Change45.21

RATIOS/PROFITABILITY

  • EPS (TTM)4.08
  • P/E (TTM)5.14
  • Fwd P/E (NTM)4.80
  • EBITDA (TTM)1.579B
  • ROE (TTM)75.12%
  • Revenue (TTM)6.347B
  • Gross Margin (TTM)59.04%
  • Net Margin (TTM)16.50%
  • Debt To Equity (MRQ)18,154.17%

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date05/10/2024
  • Div Amount0.28
  • Split Date-
  • Split Factor-

Latest On Organon & Co

Profile

MORE
Organon & Co. is a global health care company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies and medical devices within women's health, biosimilars and established brands. It has a portfolio of contraception and fertility brands, including Nexplanon, NuvaRing, and Follistim AQ. The Company’s Biosimilars portfolio spans across immunology and oncology treatments. It also has a portfolio of established brands...
Carrie Cox
Independent Chairman of the Board
Kevin Ali
Chief Executive Officer, Director
Matthew Walsh
Chief Financial Officer, Executive Vice President
Geralyn Ritter
Executive Vice President, Head of External Affairs and ESG
Kirke Weaver
Executive Vice President, General Counsel, Corporate Secretary
Address
30 Hudson Street, Fl 33
Jersey City, NJ
07302
United States

Top Peers

SYMBOLLASTCHG%CHG
PRGO
Perrigo Company PLC
30.80+0.09+0.29%
ELAN
Elanco Animal Health Inc
17.00UNCHUNCH
CTLT
Catalent Inc
55.80-0.01-0.02%
AMRX
Amneal Pharmaceuticals Inc
6.71+0.05+0.75%
PBH
Prestige Consumer Healthcare Inc
70.50+0.11+0.16%